Parkinsonism and Related Disorders

Journal

Publication Venue For

  • Accuracy and precision of wrist-worn actigraphy for measuring steps taken during over-ground and treadmill walking in adults with Parkinson's disease.  88:102-107. 2021
  • Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysis.  86:52-57. 2021
  • Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.  78:56-60. 2020
  • Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?.  69:34-39. 2019
  • Hypertension and progressive supranuclear palsy.  66:166-170. 2019
  • Motor phenotype classification in moderate to advanced PD in BioFIND study.  65:178-183. 2019
  • Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).  62:201-209. 2019
  • Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders.  61:77-81. 2019
  • Self-reported physical activity levels and clinical progression in early Parkinson's disease.  61:118-125. 2019
  • Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms.  60:126-132. 2019
  • Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.  60:138-145. 2019
  • Self-report depressive symptoms are dissociated from tremor severity in essential tremor.  50:87-93. 2018
  • Anti-inflammatory drug use and progressive supranuclear palsy.  48:89-92. 2018
  • Thalamic DBS with a constant-current device in essential tremor: A┬ácontrolled clinical trial.  40:18-26. 2017
  • Understanding falls in progressive supranuclear palsy.  35:75-81. 2017
  • Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.  28:29-35. 2016
  • Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.  28:41-48. 2016
  • Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.  27:102-106. 2016
  • Reversible improvement in severe freezing of gait from Parkinson's disease with unilateral interleaved subthalamic brain stimulation.  21:1469-1470. 2015
  • Parkinson's disease severity and use of dopaminergic medications.  21:297-299. 2015
  • Orthostatic tremor and parkinsonism.  21:541. 2015
  • Impaired financial abilities in Parkinson's disease patients with mild cognitive impairment and dementia.  19:986-990. 2013
  • Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results.  19:339-345. 2013
  • Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease.  18:63-68. 2012
  • A long-term study of istradefylline in subjects with fluctuating Parkinson's disease.  16:423-426. 2010
  • O.045 Mechanisms of dystonia.  15:S12-S12. 2009
  • Weight changes associated with unilateral STN DBS and advanced PD.  15:709-711. 2009
  • Greater motor improvement in right hemibody Parkinson's patients after dopaminergic medications.  15:20-23. 2009
  • A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.  14:77-80. 2008
  • Treatment of depression in Parkinson's disease.  10. 2004
  • A family with a tau P301L mutation presenting with parkinsonism.  9:121-123. 2002
  • Movement disorders in AIDS: Infective, neoplastic and iatrogenic causes.  1:13-19. 1995
  • International Standard Serial Number (issn)

  • 1353-8020
  • Electronic International Standard Serial Number (eissn)

  • 1873-5126